683 Capital Management »

Avidity Biosciences Ord shares owned by 683 Capital Management

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0M 70k 72.13

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
BlackRock
Wellington Management Company
RA Capital Management
venBio Select Advisor
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Norges Bank Investment Management
Bellevue Group
Glazer Capital
UBS Group
Susquehanna International

View all funds holding Avidity Biosciences Ord